businesspress24.com - Immunotec Announces Recent Claim
 

Immunotec Announces Recent Claim

ID: 1231562

(firmenpresse) - VAUDREUIL-DORION, QUEBEC -- (Marketwired) -- 05/29/13 -- Immunotec Inc. (TSX VENTURE: IMM), a Canadian based company and a leader in the wellness industry (the "Company"), today announced that it has recently received a demand letter from Mr. Robert M. Henry, former Chairman of the Board of Directors and CEO of the Company, claiming the amount of approximately $1.1 million in relation to the termination of his employment and other claims on Friday, May 10, 2013.

The Company has retained the services of an experienced labour and employment lawyer to assist and represent it in this matter. While the Company will attempt to reach an amicable and reasonable settlement with Mr. Henry, should this not be possible, it will vigorously defend its interests and those of its shareholders.

About Immunotec Inc.

Immunotec is a world class business opportunity supported by unique scientifically proven products that improve wellness. Headquartered with manufacturing facilities near Montreal, Canada, the Company also has distribution capacities to support its commercial activities in Canada and internationally to the United States, Europe, Mexico and the Caribbean.

The Company files its consolidated financial statements, its management and discussion analysis report, its press releases and such other required documents on the SEDAR database at and on the Company's website at . The common shares of the Company are listed on the TSX Venture Exchange under the ticker symbol IMM.

CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain statements contained in this news release are forward-looking and are subject to numerous risks and uncertainties, known and unknown. For information identifying known risks and uncertainties and other important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the heading Risks and Uncertainties in Immunotec's most recent Management's Discussion and Analysis, which can be found at . Consequently, actual results may differ materially from the anticipated results expressed in these forward-looking statements.





Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.



Contacts:
Patrick Montpetit CPA;CA CF,
Vice president and Chief Financial Officer
Immunotec Inc.
(450) 510-4527


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  La Jolla Pharmaceutical Company Reports Results From GCS-100 Phase 1 Chronic Kidney Disease Clinical Trial
EnergyXchange Life and Body Science: Integrated Fitness Studio Modernizes the Clinic Experience
Bereitgestellt von Benutzer: Marketwired
Datum: 29.05.2013 - 06:30 Uhr
Sprache: Deutsch
News-ID 1231562
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

VAUDREUIL-DORION, QUEBEC


Phone:

Kategorie:

Health & Nutrition


Anmerkungen:


Diese Pressemitteilung wurde bisher 142 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Immunotec Announces Recent Claim
"
steht unter der journalistisch-redaktionellen Verantwortung von

Immunotec Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Immunotec Inc.



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 1
Guests online: 92


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.